Krebs Biochemicals & Industries Ltd. (KREBSBIO): Krebs Biochemicals & Industries Share Price rises 16.72% to Rs 65
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Krebs Biochemicals Share Price is in focus today after KREBSBIO rose 16.72% to Rs 65, up from Rs 55.69, with market capitalisation at Rs 120.07 crore as of 09 September 2026 at 10:22:54 AM IST. The latest Univest data confirms a sharp share price gain, but it does not establish a company-specific catalyst. That makes the move relevant from a stock news perspective because the market is reacting to price action even as the underlying trigger remains unverified.
For readers tracking Krebs Biochemicals Share Price Today, the main question is whether the move is backed by valuation comfort, business quality or sector-relative positioning. Univest will help investors follow Krebs Biochemicals Share Price Live, Krebs Biochemicals Stock News and Krebs Biochemicals Share News with a structured view of fundamentals and industry comparison. The stock is trading near the day’s high of Rs 65 after opening at Rs 59, which keeps attention on how far today’s share price rise can be interpreted through the available financial context.
Krebs Biochemicals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 65 |
| Previous Close | Rs 55.69 |
| Today's Move | Rs 9.31 (+16.72%) |
| Open | Rs 59 |
| High | Rs 65 |
| Low | Rs 58.85 |
| Turnover | Rs 0.02 crore |
| Market Capitalisation | Rs 120.07 crore |
| Market Cap Category | Micro Cap |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) rose to Rs 65 from the previous close of Rs 55.69, a move of Rs 9.31 or 16.72%. The stock opened at Rs 59, reached a high of Rs 65, recorded a low of Rs 58.85.
Krebs Biochemicals Share Price Today shows a clear intraday gain, with the stock moving from the previous close of Rs 55.69 to Rs 65. The day change of Rs 9.31 translates into a 16.72% rise, while the session range has stayed between Rs 58.85 and Rs 65. In simple terms, KREBSBIO has been one of the more noticeable Stocks in News and a top gainer today on price alone. The turnover stood at Rs 0.02 crore, which provides a small cash-value context for the move without changing the fact that the price event is the main development. For Stock Market Today readers, this is a straightforward price action story rather than a confirmed event-driven rerating.
Krebs Biochemicals & Industries Ltd. (KREBSBIO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 120.07 crore |
| P/B Ratio | -0.72x |
| ROE | 0% |
| ROCE | -29.92% |
| EPS | Rs -6.54 |
| Book Value Per Share | Rs -76.83 |
| Dividend Yield | 0% |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) fundamental metrics show P/B -0.72x, ROE 0%, ROCE -29.92%. These figures provide context only and are not a buy or sell signal.
Krebs Biochemicals & Industries Ltd. has a market capitalisation of Rs 120.07 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at -0.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0% and ROCE of -29.92%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -6.54, book value per share of Rs -76.83, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.19x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.19x |
| Benchmark Average P/E | 49.13x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | -0.72x |
| Benchmark Median P/B | 3.05x |
| Company ROE | 0% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | -29.92% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 120.07 crore |
| Benchmark Median Market Cap | Rs 715.6 crore |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Krebs Biochemicals & Industries Ltd. (KREBSBIO) has a ROE of 0%, which is below the benchmark median of 11.82%, a difference of -100%. Krebs Biochemicals & Industries Ltd. (KREBSBIO) has a ROCE of -29.92%, which is below the benchmark median of 13.71%, a difference of -318.23%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,825.66 | 37.31 | 5.22 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,018.51 | 86.86 | 14.38 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,86,874.73 | 86.55 | 21.03 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,211.69 | 25.42 | 4.25 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,773 | 33.17 | 3.18 | 11.83 | 16 |
Its ROE of 0% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at -29.92% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Krebs Biochemicals & Industries Ltd. (KREBSBIO) has a market capitalisation of Rs 120.07 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Krebs Biochemicals
- Krebs Biochemicals Share Price rose 16.72% to Rs 65, making it one of the more visible Stocks Rising Today.
- The stock traded between Rs 58.85 and Rs 65, so today’s price action stayed near the upper end of the intraday range.
- Market capitalisation of Rs 120.07 crore keeps Krebs Biochemicals in a small-cap segment where price moves can draw attention quickly.
- Fundamentals such as EPS of -6.54, book value of -76.83 and ROCE of -29.92 remain weak versus the industry backdrop.
- The healthcare sector context matters because peer names are much larger and stronger on ROE, ROCE and valuation multiples.
About Krebs Biochemicals & Industries
Krebs Biochemicals & Industries Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is listed on NSE as KREBSBIO and also trades on BSE. Its latest Univest profile places the business in a small-cap bracket with market capitalisation of Rs 120.07 crore. The company’s current financial snapshot shows negative EPS, negative book value and negative ROCE, which means investors are likely to focus more on future business improvement than on present profitability indicators.
For readers searching Krebs Biochemicals Company News or Krebs Biochemicals Stock News Today, the main point is that today’s share price rise has to be understood alongside the company’s operating profile. the latest Univest figures show a business that belongs to a broad pharmaceutical industry with strong peers, but one that is currently valued very differently from the larger names in the sector. Univest keeps this company on the radar for investors who monitor Stock Updates, Market Movers and small-cap healthcare names.
Frequently Asked Questions
Why is Krebs Biochemicals Share Price rising today?
Ans. Krebs Biochemicals Share Price rose 16.72% to Rs 65 today. The latest Univest data confirms the move, but it does not establish a company-specific catalyst behind the gain.
What is Krebs Biochemicals Share Price today?
Ans. Krebs Biochemicals Share Price today is Rs 65. It was up by Rs 9.31 from the previous close of Rs 55.69, with market capitalisation at Rs 120.07 crore.
How much did Krebs Biochemicals stock gain today?
Ans. Krebs Biochemicals stock gained 16.72% today. The share price moved from Rs 55.69 to Rs 65, placing it among the more notable Stocks in News on price action.
What is the market cap of Krebs Biochemicals?
Ans. Krebs Biochemicals has a market capitalisation of Rs 120.07 crore. That keeps it in a small-cap category, which often means price moves can be sharp relative to company size.
Is Krebs Biochemicals financially strong based on the latest numbers?
Ans. The latest Univest figures show EPS of -6.54, book value of -76.83 and ROCE of -29.92. Those numbers do not show strong profitability or capital efficiency at present.
How does Krebs Biochemicals compare with healthcare peers?
Ans. Krebs Biochemicals is much smaller than peers such as Sun Pharma, Divi’s Laboratories and Cipla. Those companies also show stronger return ratios and higher market capitalisation in the same industry.
What does the sector comparison suggest for Krebs Biochemicals Share Price?
Ans. The sector comparison shows Krebs Biochemicals below the industry median on P/B, ROE and ROCE. That suggests today’s rise is not backed by stronger sector-relative fundamentals. The previous close was Rs 55.69.
Where is Krebs Biochemicals listed?
Ans. Krebs Biochemicals trades on NSE under KREBSBIO and is also listed on BSE. Univest tracks the stock so readers can follow Krebs Biochemicals Share Price and related stock updates.
Track Krebs Biochemicals Share Price on Univest
Use Krebs Biochemicals & Industries Ltd. (KREBSBIO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Krebs Biochemicals Share Price on Univest for live price updates, market cap, valuation ratios, financial ratios, peer comparison, sector context and company insights. Univest also helps readers monitor Krebs Biochemicals Share Price Update, Krebs Biochemicals NSE and Krebs Biochemicals BSE data in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
